These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25463482)

  • 61. Forced FOG1 expression in erythroleukemia cells: Induction of erythroid genes and repression of myelo-lymphoid transcription factor PU.1.
    Fujiwara T; Sasaki K; Saito K; Hatta S; Ichikawa S; Kobayashi M; Okitsu Y; Fukuhara N; Onishi Y; Harigae H
    Biochem Biophys Res Commun; 2017 Apr; 485(2):380-387. PubMed ID: 28216155
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells.
    Akel S; Bertolette D; Petrow-Sadowski C; Ruscetti FW
    Platelets; 2007 Dec; 18(8):566-78. PubMed ID: 18041647
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Lysophosphatidic acid regulates inflammation-related genes in human endothelial cells through LPA1 and LPA3.
    Lin CI; Chen CN; Lin PW; Chang KJ; Hsieh FJ; Lee H
    Biochem Biophys Res Commun; 2007 Nov; 363(4):1001-8. PubMed ID: 17923111
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rapamycin and bafilomycin A1 alter autophagy and megakaryopoiesis.
    Wang Q; You T; Fan H; Wang Y; Chu T; Poncz M; Zhu L
    Platelets; 2017 Jan; 28(1):82-89. PubMed ID: 27534900
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Thiazolidinedione suppresses the expression of erythroid phenotype in erythroleukemia cell line K562.
    Hirase N; Yanase T; Mu Y; Muta K; Umemura T; Takayanagi R; Nawata H
    Leuk Res; 2000 May; 24(5):393-400. PubMed ID: 10785261
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Megakaryocytic differentiation in human chronic myelogenous leukemia K562 cells induced by ionizing radiation in combination with phorbol 12-myristate 13-acetate.
    Hirose K; Monzen S; Sato H; Sato M; Aoki M; Hatayama Y; Kawaguchi H; Narita Y; Takai Y; Kashiwakura I
    J Radiat Res; 2013 May; 54(3):438-46. PubMed ID: 23263730
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1.
    Shida D; Kitayama J; Yamaguchi H; Okaji Y; Tsuno NH; Watanabe T; Takuwa Y; Nagawa H
    Cancer Res; 2003 Apr; 63(7):1706-11. PubMed ID: 12670925
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Different effects of lysophosphatidic acid receptor-2 (LPA
    Ishimoto K; Minami A; Minami K; Ueda N; Tsujiuchi T
    J Recept Signal Transduct Res; 2021 Feb; 41(1):93-98. PubMed ID: 32672083
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lysophosphatidic acid induces clonal generation of mouse neurospheres via proliferation of Sca-1- and AC133-positive neural progenitors.
    Svetlov SI; Ignatova TN; Wang KK; Hayes RL; English D; Kukekov VG
    Stem Cells Dev; 2004 Dec; 13(6):685-93. PubMed ID: 15684836
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lysophosphatidic acid receptor-2 (LPA
    Minami K; Ueda N; Ishimoto K; Tsujiuchi T
    Mol Cell Biochem; 2020 Jun; 469(1-2):89-95. PubMed ID: 32301060
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Regulator of G-protein signalling expression and function in ovarian cancer cell lines.
    Hurst JH; Mendpara N; Hooks SB
    Cell Mol Biol Lett; 2009; 14(1):153-74. PubMed ID: 18979070
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Regulation of the human prostacyclin receptor gene in megakaryocytes: major roles for C/EBPδ and PU.1.
    Keating GL; Turner EC; Kinsella BT
    Biochim Biophys Acta; 2012 May; 1819(5):428-45. PubMed ID: 22381139
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Lysophosphatidic acid receptor-2 (LPA
    Takahashi K; Minami K; Otagaki S; Ishimoto K; Fukushima K; Fukushima N; Honoki K; Tsujiuchi T
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2698-2703. PubMed ID: 30093116
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Aberrant expression and potential therapeutic target of lysophosphatidic acid receptor 3 in triple-negative breast cancers.
    Sun K; Cai H; Duan X; Yang Y; Li M; Qu J; Zhang X; Wang J
    Clin Exp Med; 2015 Aug; 15(3):371-80. PubMed ID: 25209561
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Heparanase Facilitates PMA-Induced Megakaryocytic Differentiation in K562 Cells via Interleukin 6/STAT3 Pathway.
    Wan LM; Zhang SK; Li SB; Li W; Ji SP; Gong L; Yun ZM; Zhang X; Gao HW; Zhong H; Wei CW; Bian LH; Zhuo HL; Luo Q; Li JP; Tan YX; Gong F
    Thromb Haemost; 2020 Apr; 120(4):647-657. PubMed ID: 32289862
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differential expressions and DNA methylation patterns of lysophosphatidic acid receptor genes in human colon cancer cells.
    Tsujino M; Fujii M; Okabe K; Mori T; Fukushima N; Tsujiuchi T
    Virchows Arch; 2010 Dec; 457(6):669-76. PubMed ID: 20890765
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Regulation of the LPA2 receptor signaling through the carboxyl-terminal tail-mediated protein-protein interactions.
    Lin FT; Lai YJ
    Biochim Biophys Acta; 2008 Sep; 1781(9):558-62. PubMed ID: 18501721
    [TBL] [Abstract][Full Text] [Related]  

  • 78. LPA
    Uenaka M; Uyeda A; Nakahara T; Muramatsu R
    Biochem Biophys Res Commun; 2022 Apr; 598():89-94. PubMed ID: 35151977
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The LPA
    Solís KH; Romero-Ávila MT; Guzmán-Silva A; García-Sáinz JA
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201414
    [TBL] [Abstract][Full Text] [Related]  

  • 80. LPA
    Solís KH; Romero-Ávila MT; Rincón-Heredia R; García-Sáinz JA
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.